PDL BioPharma Inc (NASDAQ:PDLI)

2.58
Delayed Data
As of Dec 04
 +0.04 / +1.57%
Today’s Change
1.86
Today|||52-Week Range
3.50
+5.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues67.9M45.1M38.9M-22.5M
 
 
 
 
 
Cost of Goods Sold11.9M11.4M12.8M12.3M
 
 
 
 
 
Depreciation And Amortization1.6M1.6M1.6M1.6M
 
 
 
 
 
 
Operating ExpensesGross Income54.4M32.1M24.5M-36.5M
 
 
 
 
 
General Expenses17.4M9.6M14.1M13.4M
 
 
 
 
 
Research And Development672.0K806.0K869.0K886.0K
 
 
 
 
 
Total Operating Expenses30.9M22.6M28.4M27.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income37.0M22.5M10.5M-49.9M
 
 
 
 
 
Extraordinary Credit0.0019.2M0.000.00
 
 
Extraordinary Charge-302.0K-8.2M0.000.00
 
 
 
Interest Expense On Debt2.9M2.9M3.0M3.0M
 
 
 
 
 
Other Expenses1.6M2.0M1.9M47.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income35.5M32.6M9.4M-5.8M
 
 
 
 
 
Income Taxes-9.9M-16.3M-2.8M-1.2M
 
 
 
 
 
Minority Interest0.000.00-63.0K-95.0K
 
 
 
Net Income25.6M16.3M6.7M-4.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS143.2M141.2M128.8M118.3M
 
 
 
 
 
Shares To Calculate EPS Diluted144.2M142.6M129.4M118.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.18$0.11$0.05-$0.04
 
 
 
 
 
EPS Diluted$0.18$0.11$0.05-$0.04